4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-018613
Chief Executive Officer gave up 9,640 shares (to pay taxes)
- Chief Executive Officer acquired 20,834 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2022-03-10 | Option exercise | +11,834 | 290,919 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2022-03-11 | Shares withheld for taxes | −5,487 | $62.56 | $343,267 | 285,432 | D |
| Kulkarni Samarth Chief Executive Officer | 2022-03-11 | Option exercise | +9,000 | 294,432 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2022-03-14 | Shares withheld for taxes | −4,153 | $61.08 | $253,665 | 290,279 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2022-03-10 | Option exercise · Restricted Stock Units | −11,834 | 11,833 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2022-03-11 | Option exercise · Restricted Stock Units | −9,000 | 27,000 | D | ||
Loading xslF345X03/doc4.xml…